Sitemap

Pages

• About Us
  • CAP
    • January 2014 CAP Meeting Materials
    • September 2014 CAP Meeting Materials
    • September 2016 CAP Meeting Materials
    • September 2017 CAP Meeting Materials
    • September 2018 CAP Meeting Materials
• Adherence Initiative for Medication Management (AIM)
• Awards and Recognition
• Calendar
• California
• Call Me
• Careers
• CareKinesis White Papers
• CII-CIV Med Access
• Contact Us
• COVID-19 Resources for PACE
  • COVID-19 Drug Information Guide
• Education & Events
  • CareKinesis Clinical Webinars
  • Educational Webinar Access Request Form
  • Published Research
• EireneRx Access
• EireneRx e-Rx Certification
• EireneRx®
  • Access Request Form
  • CareKinesis Reports
  • Disclosures
  • EireneRx Training Videos
  • Precision Prescribing
• Emergency Alert
• Enhanced MTM
• Ernest
• For Established PACE Organizations
• Home
• Leadership
  • Brian W. Adams
  • Calvin H. Knowlton, BScPharm, MDiv, PhD
  • Joseph J. Filippoli, MBA
  • Michael Greenhalgh, BScPharm, RPh
  • Michael J. Ristagno, PharmD, MBA
  • Michael S. Awadalla, PharmD, BCGP
  • Orsula V. Knowlton, PharmD, MBA
  • Robert L. Alesiani, PharmD, BCGP
  • Thomas N. Wilson
• Lillian
• Mary
• MedWise Risk Score™ Webinars
• New or Pre-PACE Organizations
• Other Services
  • PharmacoGenomics (PGx)
• PACE Pharmacy Services
  • 24/7 PharmD Support and PharmD Consultation
  • Case Studies
    • A Systematized Approach to Pharmacy
    • Eliminating Errors, Reducing Drug Interactions, and Improving Efficiency
    • Increasing Medication Management and Adherence with the MedaCube™
    • Innovation Exceeding Expectations
    • Innovative PACE Medication Management Services
    • Innovative PACE Medication Management Services
    • Innovative Pharmacy Solutions for a PACE Start-up
    • Medication Adherence Programming
    • Medications in Transition
    • PACE Case: Adacel Vs. Boostrix
    • PACE Case: Amputation Risk Averted
    • PACE Case: Cancer Pain Control
    • PACE Case: Cymbalta + Cipro
    • PACE Case: Decreasing Competitive Inhibition to Increase Response
    • PACE Case: Diabetes Management
    • PACE Case: Diazepam & Verapamil
    • PACE Case: Edema
    • PACE Case: Falls Assessment
    • PACE Case: GERD + HIV Therapy
    • PACE Case: Glycemic Control
    • PACE Case: Hydrochlorothiazide and Lithium
    • PACE Case: Hypomagnesemia
    • PACE Case: Improved Pain Control
    • PACE Case: Improving Painful Symptoms Associated with Parkinson’s Disease
    • PACE Case: Improving Parkinson’s Symptom Control
    • PACE Case: Interstitial Nephritis
    • PACE Case: Med Interruptions = Relief? (digoxin)
    • PACE Case: Mental Health Stabilization and Risk Reduction
    • PACE Case: Most Appropriate Antidepressant for a Cardiac Patient
    • PACE Case: MRM Opportunities
    • PACE Case: Optimizing Medications through Pharmacogenomic Testing
    • PACE CASE: Optimizing Pain Management and Deprescribing
    • PACE Case: Pain Control ESRD Diabetes
    • PACE Case: Pharmacogenomic Testing Utility in Mental Health
    • PACE Case: Phenytoin
    • PACE Case: Recommending Precautionary Tests
    • PACE Case: Reducing Potential Cardiovascular Events
    • PACE CASE: Restlessness and Uncontrollable Facial Movements
    • PACE Case: Risk Score Reduction Recommendations
    • PACE Case: Risperidone Alternatives for Elevated QTc
    • PACE Case: Transitioning to a Comfort Care Path
    • PACE Case: Treating Infection in Complicated Participant
    • PACE CASE: Unexplained Fatigue
    • PACE Case: When Citalopram 20mg is not Citalopram 20mg
    • Scalable Pharmacy Solutions for ArchCare
    • Solutions for a Continuing Care Retirement Community Organization
    • Using Technology to Increase Operational Efficiency
  • PACE Pharmacy Custom Adherence Packaging
  • What is PACE?
• Password Test
• Press Releases
  • In the News
  • Newsletters
• Privacy Policy
• Restless Leg Syndrome (RLS)
• Security
• Sitemap
• Terms